C&G Editor in Chief, Erin Harris

  1. What Are Smart mRNAs? 7/1/2024

    Strand Therapeutics' programmable, "smart," mRNA therapeutics could deliver precise, potentially curative treatments for solid tumors and hematological malignancies.

  2. mRNA Delivering Full-length Dystrophin for DMD 6/24/2024

    Elixirgen Therapeutics' Aki Ko shares that is conceivable that delivery of a normal, full-length dystrophin protein would address issues seen with other dystrophin replacement approaches for DMD.

  3. New Report Solidifies Greater Philadelphia Region as Global CGT Leader 5/30/2024

    A new comprehensive regional snapshot of the CGT industry shows how cell and gene therapy has become one of the most important economic drivers in the Greater Philadelphia Region over the past decade.

  4. Pediatric Patient Access With Dr. Bambi Grilley 5/29/2024

    ISCT's Chief Regulatory Officer, Dr. Bambi Grilley, Ph.D., shares insight on CGT's global regulatory landscape and the differences between the pediatric and adult patient journey.

  5. ISCT 2024 With Dr. Bruce Levine 5/23/2024

    Here are highlights, quotes, and more from Episode 76 of Cell & Gene: The Podcast featuring Dr. Bruce Levine.

  6. Is A One-Time Cure for HIV on the Horizon? 5/14/2024

    Addimmune's CMO, Dr. Marcus Conant, shares information about the company's lead asset, AGT103-T, which has been designed to provide a functional cure for HIV.

  7. Cell & Gene: The Podcast Post-Episode Recap: BlueRock Therapeutics' Dr. Ahmed Enayetallah 4/30/2024

    This article shares highlights from Cell & Gene: The Podcast featuring BlueRock Therapeutics’ Dr. Ahmed Enayetallah. Heshares impressive data from the Phase 1 study to treat Parkinson's disease.

  8. Cell & Gene: The Podcast Post-Episode Recap: Vor Bio's Dr. Robert Ang 4/26/2024

    Welcome to my new article series, Cell & Gene: The Podcast Post-Episode Recap, which shares highlights, quotes, and more from recently aired episodes of Cell & Gene: The Podcast.

  9. 2024: The Year of Development in Cell Therapy 4/10/2024

    We break down three trends driving development in cell therapy in 2024.

  10. Nanoscope Therapeutics Tackling Vision Loss With Ocular Gene Therapy 3/27/2024

    Leaders from Nanoscope Therapeutics explain the safety and efficacy data from as well as next steps for the company's RESTORE trial.